Ovarian, Fallopian Tube, and Primary Peritoneal Cancer—Health Professional Version
Ovarian epithelial, fallopian tube, and peritoneal cancers are diseases in which malignant cells form in the tissue covering the ovary, lining the fallopian tube, or peritoneum. Find evidence-based information on ovarian cancer treatment, causes and prevention, screening, research, genetics and statistics.
Treatment of Ovarian, Fallopian Tube, and Primary Peritoneal Cancers
-
Ovarian Epithelial, Fallopian, & Peritoneal Cancer Treatment (PDQ®)
Get detailed information about these cancers, (newly diagnosed or recurrent) and how they are treated in this summary for clinicians.
-
Ovarian Germ Cell Tumors Treatment (PDQ®)
Get detailed treatment information for newly diagnosed or recurrent germ cell tumors in this summary for clinicians.
-
Ovarian Borderline Tumors Treatment (PDQ®)
Get detailed treatment information in this summary for clinicians.
-
Childhood Ovarian Cancer Treatment (PDQ®)
This evidence-based, expert-reviewed summary discusses the clinical presentation, risk factors, histology, molecular features, prognosis, and treatment of pediatric ovarian cancer.
-
Childhood Extracranial Germ Cell Tumors Treatment (PDQ®)
Get detailed treatment information for newly diagnosed and recurrent extracranial GCTs in this summary for clinicians.
Additional Treatment Information
-
Treatment Clinical Trials for Ovarian Cancer
Find a list of ovarian cancer treatment clinical trials and use filters to refine the results.
-
Drugs Approved for Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for ovarian cancer.
Genetics
-
Genetics of Breast and Gynecologic Cancers (PDQ®)
Genetics of Breast and Gynecologic Cancers includes the hereditary cancer syndromes BRCA1/BRCA2 (hereditary breast and ovarian cancer), Lynch syndrome and other genes. Get comprehensive information on these syndromes in this clinician summary.
-
BRCA1 and BRCA2: Cancer Risks and Management (PDQ®)
This summary contains information about the cancer risks associated with BRCA1/BRCA2, screening, risk-reduction, treatment, and prognosis.
-
PALB2 and Associated Cancer Risks (PDQ®)
Evidence-based, expert-reviewed summary about the PALB2 gene, the cancer risks associated with PALB2, screening, risk-reduction, treatment, and prognosis.
-
Rhabdoid Tumor Predisposition Syndrome Type 2 (PDQ®)
Rhabdoid Tumor Predisposition Syndrome Type 2 (RTPS2) is a hereditary cancer syndrome associated with the SMARCA4 gene. Learn about RTPS2's clinical features and management.
-
BRCA Gene Changes: Cancer Risk and Genetic Testing
A fact sheet about the BRCA1 and BRCA2 genes, how BRCA1 and BRCA2 gene mutations (changes) affect a person's risk of cancer, genetic testing for cancer risk, interpreting test results, and the benefits and risks of genetic testing.
-
Cancer Genetics Risk Assessment and Counseling (PDQ®)
Get more information including the ethical, legal, and social implications of genetic testing in this summary for clinicians.
Screening and Prevention
-
Ovarian, Fallopian Tube, & Primary Peritoneal Cancers Screening
Get detailed information about the potential benefits and harms of screening tests used in these cancers in this summary for clinicians.
-
Ovarian, Fallopian Tube, and Primary Peritoneal Cancers Prevention (PDQ®)
Get detailed information about specific risk and protective factors and prevention strategies for these cancer types in this clinician summary.
-
Menopausal Hormone Therapy and Cancer
A fact sheet about the results of research on menopausal hormone therapy. Includes information about the effect of menopausal hormone therapy on the body.
-
Oral Contraceptives and Cancer Risk
Learn what the research says about cancer risk associated with the use of birth control pills.